Wednesday, September 16, 2020

Addition of Docetaxel to Hormonal Therapy in Low- And High-Burden Metastatic Hormone Sensitive Prostate Cancer: Long-Term Survival Results From the STAMPEDE Trial
















































 

No comments:

Post a Comment

Seminar: Cohort study design